ATF6 inhibitors and uses thereof
US12325702B2 · kind B2 · utility
0Cited by
7References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2023 |
| Grant date | Jun 10, 2025 |
| Priority date | — |
| Expiry date | May 26, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds as inhibitors of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.